7 articles
Cervical cancer
Cervical cancer, a malignant neoplasm of the cervix caused by persistent high-risk HPV (types 16 and 18 dominate), is the fourth most common cancer in women, with about 662,000 cases and 349,000 deaths in 2022, preventable by HPV vaccination and HPV-based screening.
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is an abnormal, noncancerous change in cervix surface cells, usually caused by HPV and graded 1 to 3 by severity.
Gardasil
Gardasil is Merck's quadrivalent HPV 6/11/16/18 vaccine, FDA-approved in 2006 as the first cervical cancer-preventing vaccine; Gardasil 9 (2014) adds five types and is the only HPV vaccine in the U.S.
Genital wart
Genital warts (condyloma acuminata, anogenital warts) are benign HPV-caused growths of genital skin and mucosa, 90% from HPV types 6 or 11, treated by topical or ablative therapies and prevented by vaccination.
Human papillomavirus infection
Human papillomavirus (HPV) infection, a common sexually transmitted infection with about 200 virus types; most clear spontaneously, but persistent high-risk types cause cervical, anogenital, and oropharyngeal cancers, preventable by HPV vaccination and screening.
Laryngeal papillomatosis
Laryngeal papillomatosis, or recurrent respiratory papillomatosis (RRP), is a rare HPV 6/11-caused disease with recurrent benign airway tumors, mostly in the larynx, treated by repeated surgery, bevacizumab, and the 2025-approved immunotherapy Papzimeos.
Papilloma
Papilloma: a benign epithelial tumor, usually exophytic; also called condyloma when HPV-caused on genitals. Covers squamous papillomas, warts, and HPV-independent forms like intraductal papilloma.